Sign in
CompletedNo phase

Plantar Load Analysis of Neuropathic and Neuroischaemic Diabetes-Related Foot Ulceration

Key facts

Who runs it
The Leeds Teaching Hospitals NHS Trust
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
16 people enrolled
Started
25 Oct 2025
Ended
1 Apr 2026
Type of study
Observational, 2 groups
Treatments tested
  • Pedar™ In-Shoe Plantar Pressure Measurement System
  • STAMPS 3D Digital Image Correlation System
  • Weight-Bearing Ultrasound of the Plantar Fat Pad
Record updated
28 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age > 18 years
  • Confirmed diabetes mellitus (type 1 or 2)
  • Recently healed plantar DFU (forefoot, <3months)
  • Able to walk 10m unaided
  • Able to provide written consent

Who cannot take part

  • Previous ipsilateral minor amputation or contralateral major lower limb amputation
  • Active ulceration or infection
  • Hindfoot or non-plantar ulcer location
  • Non-diabetic aetiology
  • Need for a walking aid
  • Inability to understand English instructions

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This single-centre observational case-control study investigates how peripheral arterial disease influences plantar load in people with diabetes who have recently healed a plantar foot ulcer. Using in-shoe pressure mapping (Pedar™) and 3D digital image correlation of a plasticine deformable insole (STAMPS system), we will quantify vertical pressure and strain magnitude. Weight-bearing ultrasound will assess plantar fat-pad thickness as a potential corollary for forefoot peak pressure and shear. All procedures are non-invasive and completed in a single ~90-minute visit at Leeds Teaching Hospitals NHS Trust.

The 2 groups in the trial

  • Neuropathic Diabetes-related Foot Ulcer (DFU) Cohort

    Participants with diabetes and a recently healed plantar forefoot (\<3 months) ulcer caused by neuropathic ulceration in the presence of preserved perfusion. Sensory neuropathy is confirmed by insensitivity to the 10 g monofilament (Ipswich Touch Test). Participants have at least one palpable pedal pulse and at least one multiphasic pedal Doppler signal, with opening toe pressure ≥ 60 mmHg. No history of lower-limb revascularisation.

    Treatment: Pedar™ In-Shoe Plantar Pressure Measurement System, STAMPS 3D Digital Image Correlation System, and Weight-Bearing Ultrasound of the Plantar Fat Pad

  • Neuroischaemic Diabetes-related Foot Ulcer (DFU) Cohort

    Participants with diabetes and a recently healed plantar forefoot (\<3 months) of neuroischaemic aetiology, showing both sensory neuropathy and peripheral arterial disease. PAD is defined as a prior revascularisation procedure or by the absence of pedal pulses and monophasic or absent Doppler signal with an opening toe pressure ≤ 50 mmHg.

    Treatment: Pedar™ In-Shoe Plantar Pressure Measurement System, STAMPS 3D Digital Image Correlation System, and Weight-Bearing Ultrasound of the Plantar Fat Pad

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Plantar Load Analysis of Neuropathic and Neuroischaemic Diabetes-Related Foot Ulceration (PLANE-DFU): Investigating Plantar Pressure and Shear in Neuropathic Versus Neuroischaemic Diabetes-Related Foot Ulceration
Record updated
28 October 2026